Randomized Clinical Trial Aimed at Comparing Unclamped Robotic Partial Nephrectomy With or Without Renorrhaphy
Not Applicable
Recruiting
- Conditions
- Kidney Cancer
- First Posted Date
- 2025-02-25
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 248
- Registration Number
- NCT06846112
- Locations
- ๐ฎ๐น
"Regina Elena" National Cancer Institute, Rome, Italy
A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer.
Recruiting
- Conditions
- Endometrium Cancer
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 40
- Registration Number
- NCT06841653
- Locations
- ๐ฎ๐น
IRCCS National Cancer Institute "Regina Elena", Rome, Italy
Patients with Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention
Recruiting
- Conditions
- Squamous Cell Carcinoma of Oropharynx
- First Posted Date
- 2025-02-11
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 40
- Registration Number
- NCT06821243
- Locations
- ๐ฎ๐น
IRCCS National Cancer Institute "Regina Elena", Rome, Italy
Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential
Recruiting
- Conditions
- NSCLC
- First Posted Date
- 2025-02-04
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 256
- Registration Number
- NCT06807307
- Locations
- ๐ฎ๐น
IRCCS National Cancer Institute "Regina Elena", Rome, Italy
Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer
Recruiting
- Conditions
- Head and Neck Tumors
- First Posted Date
- 2025-01-24
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 18
- Registration Number
- NCT06791941
- Locations
- ๐ฎ๐น
IRCCS National Cancer institute, Roma, Rome, Italy
MALE Mamm Organoids
Recruiting
- Conditions
- Breast Neoplasms, Male
- First Posted Date
- 2025-01-22
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 7
- Registration Number
- NCT06786663
- Locations
- ๐ฎ๐น
IRCCS National Cancer Institute "Regina Elena", Rome, Italy
Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases
Recruiting
- Conditions
- Colo-rectal Cancer
- First Posted Date
- 2025-01-22
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 10
- Registration Number
- NCT06787625
- Locations
- ๐ฎ๐น
"Regina Elena" National Cancer Institute, Rome, Italy
Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab
Phase 2
Recruiting
- Conditions
- Small Cell Lung Cancer
- Interventions
- Radiation: Thoracic radiotherapyDrug: Atezolizumab 1200 mg e.v. q21
- First Posted Date
- 2025-01-13
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 37
- Registration Number
- NCT06771518
- Locations
- ๐ฎ๐น
"Regina Elena" National Cancer Institute, Rome, Italy
Repeatability and Reproducibility of the ADC Map in Head and Neck Cancer. Prospective Multicenter Study
Recruiting
- Conditions
- Head and Neck Carcinoma
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 150
- Registration Number
- NCT06749301
- Locations
- ๐ฎ๐น
IRCCS National Cancer Institute "regina Elena", Rome, Italy
Myo-inositol and Selenium in Indeterminate Thyroid Nodules (TIR3a)
Not Applicable
Recruiting
- Conditions
- Thyroid Nodule
- First Posted Date
- 2024-12-16
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Regina Elena Cancer Institute
- Target Recruit Count
- 30
- Registration Number
- NCT06736015
- Locations
- ๐ฎ๐น
Regina Elena National Cancer Institute, Rome, Italy
ยฉ Copyright 2025. All Rights Reserved by MedPath